FDA approves updated COVID-19 boosters
Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…
COVID-19 hospitalizations, deaths increasing
Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…
New Omicron subvariant emerging
Editor's Note The World Health Organization on March 30 reported that although there is an overall downward trend in COVID-19 cases and deaths, 21 countries are reporting increases in cases of Omicron subvariant XBB.1.16, particularly India. XBB.1.16 has a similar profile to XBB.1.5, which is the dominant strain in the…
Free Daily News
- Hospital addresses barriers to patient rest, recovery
- Study: Psilocybin therapy reduces depression in frontline clinicians
- Exclusive articles preview OR Business Management Conference sessions
- Study: Surgeries improve survival in young BRCA-positive breast cancer patients
- Study: Advanced recovery room care could reduce long-term postoperative mortality
- FDA designates Class 1 recalls for balloon catheters, radiographic markers
- Orthopedic surgery in 2025: Embracing innovation, preserving autonomy
- Medtronic, Zimmer Biomet challenge Intuitive Surgical’s robotic surgery dominance
- Anthem’s anesthesia time limit policy, reversal sparks new legislation
- Simple procedure or ‘surgery’? Questionable medical billing practices cause confusion